Hope on the Horizon: Improving the Quality of Life for Persons Affected by Lymphedema

In honor of World Lymphedema Day on March 6, we journey to Sri Lanka to hear from persons affected by filarial lymphedema – a condition caused by the neglected tropical disease, lymphatic filariasis – and our Sri Lankan research team about our Neglected Tropical Diseases Support Center’s (NTD-SC) promising LEDoxy Clinical Trials.

The trials are testing the drug doxycycline to see if it can relieve the suffering and disfigurement of people living with lymphedema by reducing the swelling and acute attacks that persons affected experience.

Sri Lanka is one of three sites supported by USAID through NTD-SC in this effort to find hope for the 40 million people who live with this disfigurement. Mali and India are the other two sites collaborating on these USAID-funded clinical trials. Additional sites of the trial, funded by the German government, are being led by the University of Bonn. The 2-year study will be completed at the end of this year with results to be published soon after.

Also See

Clinical Drug Trials Offer Hope of Relief to Patients with Stigmatizing Lymphedema

Related

Neglected Tropical Diseases Support Center

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on LinkedIn
Share on facebook
Share on twitter
Share on linkedin

Explore More Posts

Scroll to Top